Evidence map›Paper›PMID 37024828›Full record

ArticleBMC oral health2023

Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression.

Robyn J Wright, Michelle E Pewarchuk, Erin A Marshall, Benjamin Murrary, Miriam P Rosin, Denise M Laronde, Lewei Zhang, Wan L Lam, Morgan G I Langille, Leigha D Rock

Erratum issuedAbstract read
In one paragraph

Article in BMC oral health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. bioRxiv : the preprint server for biology · 2025
    Article
  6. Altered Bacteria Abundance Is Associated With Outcomes in Head and Neck Squamous Cell Carcinoma.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Robyn J WrightDepartment of Pharmacology, Dalhousie University, Halifax, Canada. Robyn.Wright@dal.ca.
Michelle E PewarchukDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Erin A MarshallDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Benjamin MurraryDepartment of Pharmacology, Dalhousie University, Halifax, Canada.
Miriam P RosinDepartment of Cancer Control Research, British Columbia Cancer Research Centre, Vancouver, Canada.
Denise M LarondeDepartment of Cancer Control Research, British Columbia Cancer Research Centre, Vancouver, Canada.
Lewei ZhangFaculty of Dentistry, University of British Columbia, Vancouver, Canada.
Wan L LamDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
Morgan G I LangilleDepartment of Pharmacology, Dalhousie University, Halifax, Canada.
Leigha D RockDepartment of Pharmacology, Dalhousie University, Halifax, Canada.

Funding

CLONAL CHANGES IN ORAL LESIONS OF HIGH-RISK PATIENTSR01DE013124 · NIDCR · BRITISH COLUMBIA CANCER AGENCY · PI ROSIN, MIRIAM P. · 1999 to 2007
$2.1M
Optical Techniques and Oral Precancer ManagementR01DE017013 · NIDCR · BRITISH COLUMBIA CANCER AGENCY · PI ROSIN, MIRIAM P. · 2005 to 2009
$1.9M
NIDCR NIH HHS R01 DE013124NIDCR NIH HHS R01 DE017013
6 · The paper itself

Abstract

A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functional implications of the microbiome in low-grade oral epithelial dysplasia (OED) using 16S rRNA gene sequencing from annotated archival swabs in progressing (P) and non-progressing (NP) OED. We characterised the microbial community in 90 OED samples - 30 swabs from low-grade OED that progressed to cancer (cases) and 60 swabs from low-grade OED that did not progress after a minimum of 5 years of follow up (matched control subjects). There were small but significant differences between P and NP samples in terms of alpha diversity as well as beta diversity in conjunction with other clinical factors such as age and smoking status for both taxa and functional predictions. Across all samples, the most abundant genus was Streptococcus, followed by Haemophilus, Rothia, and Neisseria. Taxa and predicted functions were identified that were significantly differentially abundant with progression status (all Ps and NPs), when samples were grouped broadly by the number of years between sampling and progression or in specific time to progression for Ps only. However, these differentially abundant features were typically present only at low abundances. For example, Campylobacter was present in slightly higher abundance in Ps (1.72%) than NPs (1.41%) and this difference was significant when Ps were grouped by time to progression. Furthermore, several of the significantly differentially abundant functions were linked to the Campylobacteraceae family in Ps and may justify further investigation. Larger cohort studies to further explore the microbiome as a potential biomarker of risk in OED are warranted.

Indexed as

MicrobiotaMouth NeoplasmsChildChild, PreschoolCohort StudiesFemaleHumansInfantMaleRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNA sequencingMicrobiomeOral cancerOral epithelial dysplasiaOral microbiota

Identifiers

PMID37024828
PMCPMC10080811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.